Home » SENTRX RECEIVES ADDITIONAL INVESTMENT
SENTRX RECEIVES ADDITIONAL INVESTMENT
Sentrx, the leading provider of drug safety services, announced today that it closed a new round of financing. The investment will be used to enhance information technology, increase sales and marketing activities, and expand client support. The financing was led by Argosy Partners, a new investor for Sentrx. Argosy Partners is a leading source of growth capital for middle market manufacturing and service companies.
Emediawire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May